Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Sareum Holdings ( (GB:SAR) ) is now available.
Sareum Holdings PLC has successfully raised £1.07 million through an institutional equity fundraise by issuing 8,560,000 new ordinary shares at a price of 12.5 pence each, which is a 24% discount to the previous day’s closing price. The funds will be used to support the development of Sareum’s expanded portfolio, including SRA737, and for general working capital, potentially enhancing the company’s market position and shareholder value.
More about Sareum Holdings
Sareum Holdings PLC is a clinical-stage biotechnology company based in Cambridge, UK. It specializes in developing next-generation kinase inhibitors aimed at treating autoimmune diseases and cancer.
YTD Price Performance: -32.65%
Average Trading Volume: 180,726
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £20.61M
For an in-depth examination of SAR stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue